The global GLP-1 Drug market was valued at US$ 20430 million in 2023 and is anticipated to reach US$ 99940 million by 2030, witnessing a CAGR of 25.7% during the forecast period 2024-2030.

GLP-1 Drug Market

North American market for GLP-1 Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for GLP-1 Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of GLP-1 Drug include Eli Lilly, AstraZeneca, Sanofi, Pfizer Inc, Novo Nordisk, Boehringer Ingelheim, GlaxoSmithKline (GSK), East China Pharmaceutical Co., Ltd. and Gan & Lee Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for GLP-1 Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GLP-1 Drug.

Report Scope

The GLP-1 Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GLP-1 Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the GLP-1 Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of GLP-1 Drug Market Report

Report Metric	Details
Report Name	GLP-1 Drug Market
Accounted market size in 2023	US$ 20430 million
Forecasted market size in 2030	US$ 99940 million
CAGR	25.7%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Short-acting GLP-1 Drug Long-acting GLP-1 Drug
Segment by Application	Obesity Type 2 Diabetes (T2DM) Cardiovascular and Cerebrovascular Diseases (CVD) Non-alcoholic Steatohepatitis (NASH) Alzheimer's Disease (AD)
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Eli Lilly, AstraZeneca, Sanofi, Pfizer Inc, Novo Nordisk, Boehringer Ingelheim, GlaxoSmithKline (GSK), East China Pharmaceutical Co., Ltd., Gan & Lee Pharmaceuticals, Tonghua Dongbao, Shanghai Renhui Biopharmaceutical Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of GLP-1 Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of GLP-1 Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is GLP-1 Drug Market growing?

Ans: The GLP-1 Drug Market witnessing a CAGR of 25.7% during the forecast period 2024-2030.

What is the GLP-1 Drug Market size in 2030?

Ans: The GLP-1 Drug Market size in 2030 will be US$ 99940 million.

Who are the main players in the GLP-1 Drug Market report?

Ans: The main players in the GLP-1 Drug Market are Eli Lilly, AstraZeneca, Sanofi, Pfizer Inc, Novo Nordisk, Boehringer Ingelheim, GlaxoSmithKline (GSK), East China Pharmaceutical Co., Ltd., Gan & Lee Pharmaceuticals, Tonghua Dongbao, Shanghai Renhui Biopharmaceutical Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

What are the Application segmentation covered in the GLP-1 Drug Market report?

Ans: The Applications covered in the GLP-1 Drug Market report are Obesity, Type 2 Diabetes (T2DM), Cardiovascular and Cerebrovascular Diseases (CVD), Non-alcoholic Steatohepatitis (NASH), Alzheimer's Disease (AD)

What are the Type segmentation covered in the GLP-1 Drug Market report?

Ans: The Types covered in the GLP-1 Drug Market report are Short-acting GLP-1 Drug, Long-acting GLP-1 Drug

1 GLP-1 Drug Market Overview

1.1 Product Overview and Scope of GLP-1 Drug

1.2 GLP-1 Drug Segment by Type

1.2.1 Global GLP-1 Drug Market Value Comparison by Type (2024-2030)

1.2.2 Short-acting GLP-1 Drug

1.2.3 Long-acting GLP-1 Drug

1.3 GLP-1 Drug Segment by Application

1.3.1 Global GLP-1 Drug Market Value by Application: (2024-2030)

1.3.2 Obesity

1.3.3 Type 2 Diabetes (T2DM)

1.3.4 Cardiovascular and Cerebrovascular Diseases (CVD)

1.3.5 Non-alcoholic Steatohepatitis (NASH)

1.3.6 Alzheimer's Disease (AD)

1.4 Global GLP-1 Drug Market Size Estimates and Forecasts

1.4.1 Global GLP-1 Drug Revenue 2019-2030

1.4.2 Global GLP-1 Drug Sales 2019-2030

1.4.3 Global GLP-1 Drug Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 GLP-1 Drug Market Competition by Manufacturers

2.1 Global GLP-1 Drug Sales Market Share by Manufacturers (2019-2024)

2.2 Global GLP-1 Drug Revenue Market Share by Manufacturers (2019-2024)

2.3 Global GLP-1 Drug Average Price by Manufacturers (2019-2024)

2.4 Global GLP-1 Drug Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of GLP-1 Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of GLP-1 Drug, Product Type & Application

2.7 GLP-1 Drug Market Competitive Situation and Trends

2.7.1 GLP-1 Drug Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest GLP-1 Drug Players Market Share by Revenue

2.7.3 Global GLP-1 Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 GLP-1 Drug Retrospective Market Scenario by Region

3.1 Global GLP-1 Drug Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global GLP-1 Drug Global GLP-1 Drug Sales by Region: 2019-2030

3.2.1 Global GLP-1 Drug Sales by Region: 2019-2024

3.2.2 Global GLP-1 Drug Sales by Region: 2025-2030

3.3 Global GLP-1 Drug Global GLP-1 Drug Revenue by Region: 2019-2030

3.3.1 Global GLP-1 Drug Revenue by Region: 2019-2024

3.3.2 Global GLP-1 Drug Revenue by Region: 2025-2030

3.4 North America GLP-1 Drug Market Facts & Figures by Country

3.4.1 North America GLP-1 Drug Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America GLP-1 Drug Sales by Country (2019-2030)

3.4.3 North America GLP-1 Drug Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe GLP-1 Drug Market Facts & Figures by Country

3.5.1 Europe GLP-1 Drug Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe GLP-1 Drug Sales by Country (2019-2030)

3.5.3 Europe GLP-1 Drug Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific GLP-1 Drug Market Facts & Figures by Country

3.6.1 Asia Pacific GLP-1 Drug Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific GLP-1 Drug Sales by Country (2019-2030)

3.6.3 Asia Pacific GLP-1 Drug Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America GLP-1 Drug Market Facts & Figures by Country

3.7.1 Latin America GLP-1 Drug Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America GLP-1 Drug Sales by Country (2019-2030)

3.7.3 Latin America GLP-1 Drug Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa GLP-1 Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa GLP-1 Drug Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa GLP-1 Drug Sales by Country (2019-2030)

3.8.3 Middle East and Africa GLP-1 Drug Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global GLP-1 Drug Sales by Type (2019-2030)

4.1.1 Global GLP-1 Drug Sales by Type (2019-2024)

4.1.2 Global GLP-1 Drug Sales by Type (2025-2030)

4.1.3 Global GLP-1 Drug Sales Market Share by Type (2019-2030)

4.2 Global GLP-1 Drug Revenue by Type (2019-2030)

4.2.1 Global GLP-1 Drug Revenue by Type (2019-2024)

4.2.2 Global GLP-1 Drug Revenue by Type (2025-2030)

4.2.3 Global GLP-1 Drug Revenue Market Share by Type (2019-2030)

4.3 Global GLP-1 Drug Price by Type (2019-2030)

5 Segment by Application

5.1 Global GLP-1 Drug Sales by Application (2019-2030)

5.1.1 Global GLP-1 Drug Sales by Application (2019-2024)

5.1.2 Global GLP-1 Drug Sales by Application (2025-2030)

5.1.3 Global GLP-1 Drug Sales Market Share by Application (2019-2030)

5.2 Global GLP-1 Drug Revenue by Application (2019-2030)

5.2.1 Global GLP-1 Drug Revenue by Application (2019-2024)

5.2.2 Global GLP-1 Drug Revenue by Application (2025-2030)

5.2.3 Global GLP-1 Drug Revenue Market Share by Application (2019-2030)

5.3 Global GLP-1 Drug Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Eli Lilly

6.1.1 Eli Lilly Corporation Information

6.1.2 Eli Lilly Description and Business Overview

6.1.3 Eli Lilly GLP-1 Drug Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Eli Lilly GLP-1 Drug Product Portfolio

6.1.5 Eli Lilly Recent Developments/Updates

6.2 AstraZeneca

6.2.1 AstraZeneca Corporation Information

6.2.2 AstraZeneca Description and Business Overview

6.2.3 AstraZeneca GLP-1 Drug Sales, Revenue and Gross Margin (2019-2024)

6.2.4 AstraZeneca GLP-1 Drug Product Portfolio

6.2.5 AstraZeneca Recent Developments/Updates

6.3 Sanofi

6.3.1 Sanofi Corporation Information

6.3.2 Sanofi Description and Business Overview

6.3.3 Sanofi GLP-1 Drug Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Sanofi GLP-1 Drug Product Portfolio

6.3.5 Sanofi Recent Developments/Updates

6.4 Pfizer Inc

6.4.1 Pfizer Inc Corporation Information

6.4.2 Pfizer Inc Description and Business Overview

6.4.3 Pfizer Inc GLP-1 Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Pfizer Inc GLP-1 Drug Product Portfolio

6.4.5 Pfizer Inc Recent Developments/Updates

6.5 Novo Nordisk

6.5.1 Novo Nordisk Corporation Information

6.5.2 Novo Nordisk Description and Business Overview

6.5.3 Novo Nordisk GLP-1 Drug Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Novo Nordisk GLP-1 Drug Product Portfolio

6.5.5 Novo Nordisk Recent Developments/Updates

6.6 Boehringer Ingelheim

6.6.1 Boehringer Ingelheim Corporation Information

6.6.2 Boehringer Ingelheim Description and Business Overview

6.6.3 Boehringer Ingelheim GLP-1 Drug Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Boehringer Ingelheim GLP-1 Drug Product Portfolio

6.6.5 Boehringer Ingelheim Recent Developments/Updates

6.7 GlaxoSmithKline (GSK)

6.6.1 GlaxoSmithKline (GSK) Corporation Information

6.6.2 GlaxoSmithKline (GSK) Description and Business Overview

6.6.3 GlaxoSmithKline (GSK) GLP-1 Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 GlaxoSmithKline (GSK) GLP-1 Drug Product Portfolio

6.7.5 GlaxoSmithKline (GSK) Recent Developments/Updates

6.8 East China Pharmaceutical Co., Ltd.

6.8.1 East China Pharmaceutical Co., Ltd. Corporation Information

6.8.2 East China Pharmaceutical Co., Ltd. Description and Business Overview

6.8.3 East China Pharmaceutical Co., Ltd. GLP-1 Drug Sales, Revenue and Gross Margin (2019-2024)

6.8.4 East China Pharmaceutical Co., Ltd. GLP-1 Drug Product Portfolio

6.8.5 East China Pharmaceutical Co., Ltd. Recent Developments/Updates

6.9 Gan & Lee Pharmaceuticals

6.9.1 Gan & Lee Pharmaceuticals Corporation Information

6.9.2 Gan & Lee Pharmaceuticals Description and Business Overview

6.9.3 Gan & Lee Pharmaceuticals GLP-1 Drug Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Gan & Lee Pharmaceuticals GLP-1 Drug Product Portfolio

6.9.5 Gan & Lee Pharmaceuticals Recent Developments/Updates

6.10 Tonghua Dongbao

6.10.1 Tonghua Dongbao Corporation Information

6.10.2 Tonghua Dongbao Description and Business Overview

6.10.3 Tonghua Dongbao GLP-1 Drug Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Tonghua Dongbao GLP-1 Drug Product Portfolio

6.10.5 Tonghua Dongbao Recent Developments/Updates

6.11 Shanghai Renhui Biopharmaceutical Co., Ltd.

6.11.1 Shanghai Renhui Biopharmaceutical Co., Ltd. Corporation Information

6.11.2 Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Description and Business Overview

6.11.3 Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Product Portfolio

6.11.5 Shanghai Renhui Biopharmaceutical Co., Ltd. Recent Developments/Updates

6.12 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

6.12.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Corporation Information

6.12.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Description and Business Overview

6.12.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product Portfolio

6.12.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 GLP-1 Drug Industry Chain Analysis

7.2 GLP-1 Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 GLP-1 Drug Production Mode & Process

7.4 GLP-1 Drug Sales and Marketing

7.4.1 GLP-1 Drug Sales Channels

7.4.2 GLP-1 Drug Distributors

7.5 GLP-1 Drug Customers

8 GLP-1 Drug Market Dynamics

8.1 GLP-1 Drug Industry Trends

8.2 GLP-1 Drug Market Drivers

8.3 GLP-1 Drug Market Challenges

8.4 GLP-1 Drug Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Sanofi

Pfizer Inc

Novo Nordisk

GlaxoSmithKline(GSK )

Gan & Lee Pharmaceuticals

Tonghua Dongbao

Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

Astrazeneca plc

Eli Lilly

Boehringer Ingelheim

East China Pharmaceutical Co., Ltd.

Shanghai Renhui Biopharmaceutical Co., Ltd.

List of Tables

Table 1. Global GLP-1 Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global GLP-1 Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global GLP-1 Drug Market Competitive Situation by Manufacturers in 2023

Table 4. Global GLP-1 Drug Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global GLP-1 Drug Sales Market Share by Manufacturers (2019-2024)

Table 6. Global GLP-1 Drug Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global GLP-1 Drug Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market GLP-1 Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of GLP-1 Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of GLP-1 Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of GLP-1 Drug, Product Type & Application

Table 12. Global Key Manufacturers of GLP-1 Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global GLP-1 Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP-1 Drug as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global GLP-1 Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global GLP-1 Drug Sales by Region (2019-2024) & (K Units)

Table 18. Global GLP-1 Drug Sales Market Share by Region (2019-2024)

Table 19. Global GLP-1 Drug Sales by Region (2025-2030) & (K Units)

Table 20. Global GLP-1 Drug Sales Market Share by Region (2025-2030)

Table 21. Global GLP-1 Drug Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global GLP-1 Drug Revenue Market Share by Region (2019-2024)

Table 23. Global GLP-1 Drug Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global GLP-1 Drug Revenue Market Share by Region (2025-2030)

Table 25. North America GLP-1 Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America GLP-1 Drug Sales by Country (2019-2024) & (K Units)

Table 27. North America GLP-1 Drug Sales by Country (2025-2030) & (K Units)

Table 28. North America GLP-1 Drug Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America GLP-1 Drug Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe GLP-1 Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe GLP-1 Drug Sales by Country (2019-2024) & (K Units)

Table 32. Europe GLP-1 Drug Sales by Country (2025-2030) & (K Units)

Table 33. Europe GLP-1 Drug Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe GLP-1 Drug Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific GLP-1 Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific GLP-1 Drug Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific GLP-1 Drug Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific GLP-1 Drug Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific GLP-1 Drug Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America GLP-1 Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America GLP-1 Drug Sales by Country (2019-2024) & (K Units)

Table 42. Latin America GLP-1 Drug Sales by Country (2025-2030) & (K Units)

Table 43. Latin America GLP-1 Drug Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America GLP-1 Drug Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa GLP-1 Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa GLP-1 Drug Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa GLP-1 Drug Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa GLP-1 Drug Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa GLP-1 Drug Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global GLP-1 Drug Sales (K Units) by Type (2019-2024)

Table 51. Global GLP-1 Drug Sales (K Units) by Type (2025-2030)

Table 52. Global GLP-1 Drug Sales Market Share by Type (2019-2024)

Table 53. Global GLP-1 Drug Sales Market Share by Type (2025-2030)

Table 54. Global GLP-1 Drug Revenue (US$ Million) by Type (2019-2024)

Table 55. Global GLP-1 Drug Revenue (US$ Million) by Type (2025-2030)

Table 56. Global GLP-1 Drug Revenue Market Share by Type (2019-2024)

Table 57. Global GLP-1 Drug Revenue Market Share by Type (2025-2030)

Table 58. Global GLP-1 Drug Price (US$/Unit) by Type (2019-2024)

Table 59. Global GLP-1 Drug Price (US$/Unit) by Type (2025-2030)

Table 60. Global GLP-1 Drug Sales (K Units) by Application (2019-2024)

Table 61. Global GLP-1 Drug Sales (K Units) by Application (2025-2030)

Table 62. Global GLP-1 Drug Sales Market Share by Application (2019-2024)

Table 63. Global GLP-1 Drug Sales Market Share by Application (2025-2030)

Table 64. Global GLP-1 Drug Revenue (US$ Million) by Application (2019-2024)

Table 65. Global GLP-1 Drug Revenue (US$ Million) by Application (2025-2030)

Table 66. Global GLP-1 Drug Revenue Market Share by Application (2019-2024)

Table 67. Global GLP-1 Drug Revenue Market Share by Application (2025-2030)

Table 68. Global GLP-1 Drug Price (US$/Unit) by Application (2019-2024)

Table 69. Global GLP-1 Drug Price (US$/Unit) by Application (2025-2030)

Table 70. Eli Lilly Corporation Information

Table 71. Eli Lilly Description and Business Overview

Table 72. Eli Lilly GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Eli Lilly GLP-1 Drug Product

Table 74. Eli Lilly Recent Developments/Updates

Table 75. AstraZeneca Corporation Information

Table 76. AstraZeneca Description and Business Overview

Table 77. AstraZeneca GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. AstraZeneca GLP-1 Drug Product

Table 79. AstraZeneca Recent Developments/Updates

Table 80. Sanofi Corporation Information

Table 81. Sanofi Description and Business Overview

Table 82. Sanofi GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Sanofi GLP-1 Drug Product

Table 84. Sanofi Recent Developments/Updates

Table 85. Pfizer Inc Corporation Information

Table 86. Pfizer Inc Description and Business Overview

Table 87. Pfizer Inc GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Pfizer Inc GLP-1 Drug Product

Table 89. Pfizer Inc Recent Developments/Updates

Table 90. Novo Nordisk Corporation Information

Table 91. Novo Nordisk Description and Business Overview

Table 92. Novo Nordisk GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Novo Nordisk GLP-1 Drug Product

Table 94. Novo Nordisk Recent Developments/Updates

Table 95. Boehringer Ingelheim Corporation Information

Table 96. Boehringer Ingelheim Description and Business Overview

Table 97. Boehringer Ingelheim GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Boehringer Ingelheim GLP-1 Drug Product

Table 99. Boehringer Ingelheim Recent Developments/Updates

Table 100. GlaxoSmithKline (GSK) Corporation Information

Table 101. GlaxoSmithKline (GSK) Description and Business Overview

Table 102. GlaxoSmithKline (GSK) GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. GlaxoSmithKline (GSK) GLP-1 Drug Product

Table 104. GlaxoSmithKline (GSK) Recent Developments/Updates

Table 105. East China Pharmaceutical Co., Ltd. Corporation Information

Table 106. East China Pharmaceutical Co., Ltd. Description and Business Overview

Table 107. East China Pharmaceutical Co., Ltd. GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. East China Pharmaceutical Co., Ltd. GLP-1 Drug Product

Table 109. East China Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 110. Gan & Lee Pharmaceuticals Corporation Information

Table 111. Gan & Lee Pharmaceuticals Description and Business Overview

Table 112. Gan & Lee Pharmaceuticals GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Gan & Lee Pharmaceuticals GLP-1 Drug Product

Table 114. Gan & Lee Pharmaceuticals Recent Developments/Updates

Table 115. Tonghua Dongbao Corporation Information

Table 116. Tonghua Dongbao Description and Business Overview

Table 117. Tonghua Dongbao GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Tonghua Dongbao GLP-1 Drug Product

Table 119. Tonghua Dongbao Recent Developments/Updates

Table 120. Shanghai Renhui Biopharmaceutical Co., Ltd. Corporation Information

Table 121. Shanghai Renhui Biopharmaceutical Co., Ltd. Description and Business Overview

Table 122. Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Product

Table 124. Shanghai Renhui Biopharmaceutical Co., Ltd. Recent Developments/Updates

Table 125. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Corporation Information

Table 126. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Description and Business Overview

Table 127. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product

Table 129. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. GLP-1 Drug Distributors List

Table 133. GLP-1 Drug Customers List

Table 134. GLP-1 Drug Market Trends

Table 135. GLP-1 Drug Market Drivers

Table 136. GLP-1 Drug Market Challenges

Table 137. GLP-1 Drug Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of GLP-1 Drug

Figure 2. Global GLP-1 Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global GLP-1 Drug Market Share by Type in 2023 & 2030

Figure 4. Short-acting GLP-1 Drug Product Picture

Figure 5. Long-acting GLP-1 Drug Product Picture

Figure 6. Global GLP-1 Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global GLP-1 Drug Market Share by Application in 2023 & 2030

Figure 8. Obesity

Figure 9. Type 2 Diabetes (T2DM)

Figure 10. Cardiovascular and Cerebrovascular Diseases (CVD)

Figure 11. Non-alcoholic Steatohepatitis (NASH)

Figure 12. Alzheimer's Disease (AD)

Figure 13. Global GLP-1 Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global GLP-1 Drug Market Size (2019-2030) & (US$ Million)

Figure 15. Global GLP-1 Drug Sales (2019-2030) & (K Units)

Figure 16. Global GLP-1 Drug Average Price (US$/Unit) & (2019-2030)

Figure 17. GLP-1 Drug Report Years Considered

Figure 18. GLP-1 Drug Sales Share by Manufacturers in 2023

Figure 19. Global GLP-1 Drug Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest GLP-1 Drug Players: Market Share by Revenue in 2023

Figure 21. GLP-1 Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global GLP-1 Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America GLP-1 Drug Sales Market Share by Country (2019-2030)

Figure 24. North America GLP-1 Drug Revenue Market Share by Country (2019-2030)

Figure 25. United States GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe GLP-1 Drug Sales Market Share by Country (2019-2030)

Figure 28. Europe GLP-1 Drug Revenue Market Share by Country (2019-2030)

Figure 29. Germany GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific GLP-1 Drug Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific GLP-1 Drug Revenue Market Share by Region (2019-2030)

Figure 36. China GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. China Taiwan GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Southeast Asia GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America GLP-1 Drug Sales Market Share by Country (2019-2030)

Figure 44. Latin America GLP-1 Drug Revenue Market Share by Country (2019-2030)

Figure 45. Mexico GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Brazil GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Argentina GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Colombia GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa GLP-1 Drug Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa GLP-1 Drug Revenue Market Share by Country (2019-2030)

Figure 51. Turkey GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. UAE GLP-1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of GLP-1 Drug by Type (2019-2030)

Figure 55. Global Revenue Market Share of GLP-1 Drug by Type (2019-2030)

Figure 56. Global GLP-1 Drug Price (US$/Unit) by Type (2019-2030)

Figure 57. Global Sales Market Share of GLP-1 Drug by Application (2019-2030)

Figure 58. Global Revenue Market Share of GLP-1 Drug by Application (2019-2030)

Figure 59. Global GLP-1 Drug Price (US$/Unit) by Application (2019-2030)

Figure 60. GLP-1 Drug Value Chain

Figure 61. GLP-1 Drug Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Stainless Steel Medication Trolley Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-18N15820

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Instant Molecular Testing Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33G15638

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Universal Cell Therapy Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-14U15769

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Preclinical Toxicology Testing Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-1P15930

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions